Slate Pharmaceuticals Company
Slate Pharmaceuticals acquires, develops, and commercializes products for the diseases of maturing men and women.
Founded Date:
2007-01-01
Total Funding:
$9 777 000
Technology:
Physical Rehabilitation
Estimated Revenue:
$100M to $500M
Headquarters:
Durham, North Carolina, United States
Last Funding Type:
Debt Financing
Industry:
Longevity
Last Funding Date:
2010-09-24